Syringes Market Summary
As per Market Research Future Analysis, the Global Syringes Market was valued at 21.45 USD Billion in 2024 and is projected to grow to 54.81 USD Billion by 2035, reflecting a CAGR of 8.90% from 2025 to 2035. The market is driven by increasing vaccination demands, technological advancements in syringe manufacturing, and the rising prevalence of chronic diseases. The COVID-19 pandemic has further accelerated the need for disposable syringes, leading to heightened production capacities, especially in low- and middle-income countries.
Key Market Trends & Highlights
The Global Syringes Market is witnessing transformative trends that enhance healthcare delivery.
- The market is expected to grow from 6.07 USD Billion in 2024 to 10.2 USD Billion by 2035.
- Hypodermic Syringes segment valued at 2.5 USD Billion in 2024, projected to reach 54.81 USD Billion by 2035.
- Insulin Syringes segment anticipated to grow from 1.3 USD Billion in 2024 to 2.15 USD Billion by 2035.
- Safety Syringes valued at 1.27 USD Billion in 2024, expected to reach 54.81 USD Billion by 2035.
Market Size & Forecast
2024 Market Size | USD 21.45 Billion |
2035 Market Size | USD 54.81 Billion |
CAGR (2025-2035) | 8.90% |
Major Players
Nipro Corporation; Becton Dickinson and Company; Sarstedt AG and Co. KG; Owen Mumford; Dynarex Corporation; Terumo Corporation; Smiths Medical; Retractable Technologies; Medtronic; Braun Melsungen AG.